News Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-04-17 pm EDT			5-day change	1st Jan Change
157.47 ^USD	+2.31%		+3.78%	+8.89%

Apr. 17	Adicet Bio, Inc. Appoints Michael Grissinger to the Board of Directors	CI
Apr. 17	Addex Reclaims Rights to Epilepsy Drug as Janssen Ends Partnership	MT

Johnson & Johnson : First Quarter 2025 2025 First-Quarter Earnings Transcript (April 15, 2025)	Apr. 17	PU
Adicet Bio, Inc. Appoints Michael Grissinger to the Board of Directors	Apr. 17	CI
Addex Reclaims Rights to Epilepsy Drug as Janssen Ends Partnership	Apr. 17	MT
Addex Therapeutics Regains Rights for Epilepsy Drug Candidate from J&J Unit	Apr. 17	MT
Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference	Apr. 16	BU
Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer	Apr. 16	CI
BofA Securities Adjusts Price Target on Johnson & Johnson to $161 From $159, Maintains Neutral Rating	Apr. 16	MT
Abbott backs profit forecast, to invest $500 million in US amid tariffs	Apr. 16	RE
Raymond James Adjusts Price Target on Johnson & Johnson to $164 From $162, Keeps Outperform Rating	Apr. 16	MT
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $164, Keeps Equalweight Rating	Apr. 16	MT
Bernstein Adjusts Price Target on Johnson & Johnson to $159 From $158, Keeps Market Perform Rating	Apr. 16	MT
Healthcare Stocks Among Worst Performers -- Healthcare Roundup	Apr. 15	DJ
Wall Street ends down slightly; tariff uncertainty keeps investors on edge	Apr. 15	RE
Equity Markets Close Lower as Earnings Season Kicks Off	Apr. 15	MT
Sector Update: Health Care Stocks Retreat Late Afternoon	Apr. 15	MT
Wall Street dips as tariff uncertainty keeps investors on edge	Apr. 15	RE
Equities Little Changed Intraday After Corporate Earnings	Apr. 15	MT
Sector Update: Health Care Stocks Decline in Afternoon Trading	Apr. 15	MT
Sector Update: Health Care	Apr. 15	MT
US Equity Indexes Give up Gains as Investors Weigh Impact of Changing Tariffs Landscape on Economic Growth	Apr. 15	MT
Johnson & Johnson's Q1 Adjusted Earnings, Revenue Rise; Reiterates 2025 Adjusted Earnings Guidance	Apr. 15	MT
US Equity Indexes Rise Amid Reports of Trump Auto-Tariff Tweaks	Apr. 15	MT
Wall St rises on tariff relief hopes, gains in financials	Apr. 15	RE
Top Midday Stories: Elliott Takes Stake of Over $1.5 Billion in HP Enterprise; Johnson & Johnson Lifts Sales Outlook	Apr. 15	MT
J&J Expects Tariffs to Cost Company $400 Million	Apr. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

J&J Expects Tariffs to Cost Company $400 Million

April 15, 2025 at 11:30 am EDT

Johnson & Johnson: A Dose of Resilience Amid Trade Tensions

April 15, 2025 at 09:54 am EDT